Comprehensive analysis of clinical and biological value of ING family genes in liver cancer

IF 4.7 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-06-15 DOI:10.4251/wjgo.v16.i6.2592
Shi-Cai Liu
{"title":"Comprehensive analysis of clinical and biological value of ING family genes in liver cancer","authors":"Shi-Cai Liu","doi":"10.4251/wjgo.v16.i6.2592","DOIUrl":null,"url":null,"abstract":"BACKGROUND\n Liver cancer (LIHC) is a malignant tumor that occurs in the liver and has a high mortality in cancer. The ING family genes were identified as tumor suppressor genes. Dysregulated expression of these genes can lead to cell cycle arrest, senescence and/or apoptosis. ING family genes are promising targets for anticancer therapy. However, their role in LIHC is still not well understood.\n AIM\n To have a better understanding of the important roles of ING family members in LIHC.\n METHODS\n A series of bioinformatics approaches (including gene expression analysis, genetic alteration analysis, survival analysis, immune infiltration analysis, prediction of upstream microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) of ING1 , and ING1 -related gene functional enrichment analysis) was applied to study the expression profile, clinical relationship, prognostic significance and immune infiltration of ING in LIHC. The relationship between ING family genes expression and tumor associated immune checkpoints was investigated in LIHC. The molecular mechanism of ING1 mediated hepatocarcinogenesis was preliminarily discussed.\n RESULTS\n mRNA/protein expression of different ING family genes in LIHC was analyzed in different databases, showing that ING family genes were highly expressed in LIHC. In 47 samples from 366 LIHC patients, the ING family genes were altered at a rate of 13%. By comprehensively analyzing the expression, clinical pathological parameters and prognostic value of ING family genes, ING1/5 was identified. ING1/5 was related to poor prognosis of LIHC, suggesting that they may play key roles in LIHC tumorigenesis and progression. One of the target miRNAs of ING1 was identified as hsa-miR-214-3p. Two upstream lncRNAs of hsa-miR-214-3p, U91328.1, and HCG17, were identified. At the same time, we found that the expression of ING family genes was correlated with immune cell infiltration and immune checkpoint genes.\n CONCLUSION\n This study lays a foundation for further research on the potential mechanism and clinical value of ING family genes in the treatment and prognosis of LIHC.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":"4 3","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4251/wjgo.v16.i6.2592","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Liver cancer (LIHC) is a malignant tumor that occurs in the liver and has a high mortality in cancer. The ING family genes were identified as tumor suppressor genes. Dysregulated expression of these genes can lead to cell cycle arrest, senescence and/or apoptosis. ING family genes are promising targets for anticancer therapy. However, their role in LIHC is still not well understood. AIM To have a better understanding of the important roles of ING family members in LIHC. METHODS A series of bioinformatics approaches (including gene expression analysis, genetic alteration analysis, survival analysis, immune infiltration analysis, prediction of upstream microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) of ING1 , and ING1 -related gene functional enrichment analysis) was applied to study the expression profile, clinical relationship, prognostic significance and immune infiltration of ING in LIHC. The relationship between ING family genes expression and tumor associated immune checkpoints was investigated in LIHC. The molecular mechanism of ING1 mediated hepatocarcinogenesis was preliminarily discussed. RESULTS mRNA/protein expression of different ING family genes in LIHC was analyzed in different databases, showing that ING family genes were highly expressed in LIHC. In 47 samples from 366 LIHC patients, the ING family genes were altered at a rate of 13%. By comprehensively analyzing the expression, clinical pathological parameters and prognostic value of ING family genes, ING1/5 was identified. ING1/5 was related to poor prognosis of LIHC, suggesting that they may play key roles in LIHC tumorigenesis and progression. One of the target miRNAs of ING1 was identified as hsa-miR-214-3p. Two upstream lncRNAs of hsa-miR-214-3p, U91328.1, and HCG17, were identified. At the same time, we found that the expression of ING family genes was correlated with immune cell infiltration and immune checkpoint genes. CONCLUSION This study lays a foundation for further research on the potential mechanism and clinical value of ING family genes in the treatment and prognosis of LIHC.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
全面分析肝癌 ING 家族基因的临床和生物学价值
背景 肝癌(LIHC)是一种发生在肝脏的恶性肿瘤,在癌症中死亡率很高。ING家族基因被认定为肿瘤抑制基因。这些基因的表达失调可导致细胞周期停滞、衰老和/或凋亡。ING家族基因是很有希望的抗癌治疗靶点。然而,人们对它们在 LIHC 中的作用仍不甚了解。目的 更好地了解ING家族成员在LIHC中的重要作用。方法 应用一系列生物信息学方法(包括基因表达分析、基因改变分析、生存分析、免疫浸润分析、ING1上游微RNA(miRNA)和长非编码RNA(lncRNA)预测以及ING1相关基因功能富集分析)研究ING在LIHC中的表达谱、临床关系、预后意义和免疫浸润。研究还探讨了ING家族基因在LIHC中的表达与肿瘤相关免疫检查点之间的关系。初步探讨了ING1介导肝癌发生的分子机制。结果 在不同的数据库中分析了不同ING家族基因在LIHC中的mRNA/蛋白表达,结果显示ING家族基因在LIHC中高表达。在来自 366 例 LIHC 患者的 47 份样本中,ING 家族基因的改变率为 13%。通过全面分析ING家族基因的表达、临床病理参数和预后价值,确定了ING1/5。ING1/5与LIHC的不良预后有关,表明它们可能在LIHC肿瘤的发生和发展中起着关键作用。ING1的靶miRNA之一是hsa-miR-214-3p。我们还发现了hsa-miR-214-3p的两个上游lncRNA:U91328.1和HCG17。同时,我们发现 ING 家族基因的表达与免疫细胞浸润和免疫检查点基因相关。结论 本研究为进一步研究ING家族基因在LIHC治疗和预后中的潜在机制和临床价值奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊介绍: ACS Applied Bio Materials is an interdisciplinary journal publishing original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical and therapeutic applications. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrates knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bio applications. The journal is specifically interested in work that addresses the relationship between structure and function and assesses the stability and degradation of materials under relevant environmental and biological conditions.
期刊最新文献
Correction to "Three in One: In Vitro and In Vivo Evaluation of Anticancer Activity of a Theranostic Agent that Combines Magnetic Resonance Imaging, Optical Bioimaging, and Photodynamic Therapy Capabilities". Trastuzumab Conjugation Enhances HER2-Positive Cell Association and Intratumoral Retention of Magnetite Nanoparticles for Magnetic Hyperthermia. Cell Membrane Targeting via Spacer Length-Engineered Amphiphilic DNA Frameworks. Facile Microemulsion Preparation of Paclitaxel-Loaded Silk Fibroin Nanoparticles Using Polyethylene Glycol for Glioblastoma Therapy. Silk Sericin Functionalized with Carboxy Drugs for Dermocosmetic Applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1